[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Precision Medicine Market Size, Manufacturers, Opportunities and Forecast to 2030

April 2024 | 110 pages | ID: GEC8C7BA3473EN
APO Research

US$ 3,450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to the National Institutes of Health (NIH), precision medicine is 'an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.' This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a 'one-size-fits-all' approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.

Although the term 'precision medicine' is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.

According to APO Research, The global Precision Medicine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.

Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.

Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Precision Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Medicine.

The Precision Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Johnson & Johnson
  • Roche
  • Labcorp
  • Abbott Laboratories
  • Novartis
  • Illumina
  • GE Healthcare
  • Intel Corporation
  • Biomrieux Sa
  • Cepheid
  • IBM
  • Qiagen
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Almac Group
  • Healthcore
Precision Medicine segment by Type
  • Diagnostics
  • Therapies
Precision Medicine segment by Application
  • Oncology
  • Neurosciences
  • Immunology
  • Respiratory
  • Others
Precision Medicine Segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Precision Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Precision Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Precision Medicine Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Precision Medicine Market Size by Region (2019-2030)
  1.4.1 Global Precision Medicine Market Size by Region (2019-2024)
  1.4.2 Global Precision Medicine Market Size by Region (2025-2030)
1.5 Key Regions Precision Medicine Market Size (2019-2030)
  1.5.1 North America Precision Medicine Market Size Growth Rate (2019-2030)
  1.5.2 Europe Precision Medicine Market Size Growth Rate (2019-2030)
  1.5.3 Asia-Pacific Precision Medicine Market Size Growth Rate (2019-2030)
  1.5.4 Latin America Precision Medicine Market Size Growth Rate (2019-2030)
  1.5.5 Middle East & Africa Precision Medicine Market Size Growth Rate (2019-2030)

2 PRECISION MEDICINE MARKET BY TYPE

2.1 Type Introduction
  2.1.1 Diagnostics
  2.1.2 Therapies
2.2 Global Precision Medicine Market Size by Type
  2.2.1 Global Precision Medicine Market Size Overview by Type (2019-2030)
  2.2.2 Global Precision Medicine Historic Market Size Review by Type (2019-2024)
  2.2.3 Global Precision Medicine Market Size Forecasted by Type (2025-2030)
2.3 Global Precision Medicine Market Size by Regions
  2.3.1 North America Precision Medicine Market Size Breakdown by Type (2019-2024)
  2.3.2 Europe Precision Medicine Market Size Breakdown by Type (2019-2024)
  2.3.3 Asia-Pacific Precision Medicine Market Size Breakdown by Type (2019-2024)
  2.3.4 Latin America Precision Medicine Market Size Breakdown by Type (2019-2024)
  2.3.5 Middle East and Africa Precision Medicine Market Size Breakdown by Type (2019-2024)

3 PRECISION MEDICINE MARKET BY APPLICATION

3.1 Type Introduction
  3.1.1 Oncology
  3.1.2 Neurosciences
  3.1.3 Immunology
  3.1.4 Respiratory
  3.1.5 Others
3.2 Global Precision Medicine Market Size by Application
  3.2.1 Global Precision Medicine Market Size Overview by Application (2019-2030)
  3.2.2 Global Precision Medicine Historic Market Size Review by Application (2019-2024)
  3.2.3 Global Precision Medicine Market Size Forecasted by Application (2025-2030)
3.3 Global Precision Medicine Market Size by Regions
  3.3.1 North America Precision Medicine Market Size Breakdown by Application (2019-2024)
  3.3.2 Europe Precision Medicine Market Size Breakdown by Application (2019-2024)
  3.3.3 Asia-Pacific Precision Medicine Market Size Breakdown by Application (2019-2024)
  3.3.4 Latin America Precision Medicine Market Size Breakdown by Application (2019-2024)
  3.3.5 Middle East and Africa Precision Medicine Market Size Breakdown by Application (2019-2024)

4 GLOBAL MARKET DYNAMICS

4.1 Precision Medicine Industry Trends
4.2 Precision Medicine Industry Drivers
4.3 Precision Medicine Industry Opportunities and Challenges
4.4 Precision Medicine Industry Restraints

5 COMPETITIVE INSIGHTS BY COMPANY

5.1 Global Top Players by Precision Medicine Revenue (2019-2024)
5.2 Global Precision Medicine Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Precision Medicine Key Company Headquarters & Area Served
5.4 Global Precision Medicine Company, Product Type & Application
5.5 Global Precision Medicine Company Commercialization Time
5.6 Market Competitive Analysis
  5.6.1 Global Precision Medicine Market CR5 and HHI
  5.6.2 Global Top 5 and 10 Precision Medicine Players Market Share by Revenue in 2023
  5.6.3 2023 Precision Medicine Tier 1, Tier 2, and Tier

6 COMPANY PROFILES

6.1 Johnson & Johnson
  6.1.1 Johnson & Johnson Comapny Information
  6.1.2 Johnson & Johnson Business Overview
  6.1.3 Johnson & Johnson Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.1.4 Johnson & Johnson Precision Medicine Product Portfolio
  6.1.5 Johnson & Johnson Recent Developments
6.2 Roche
  6.2.1 Roche Comapny Information
  6.2.2 Roche Business Overview
  6.2.3 Roche Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.2.4 Roche Precision Medicine Product Portfolio
  6.2.5 Roche Recent Developments
6.3 Labcorp
  6.3.1 Labcorp Comapny Information
  6.3.2 Labcorp Business Overview
  6.3.3 Labcorp Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.3.4 Labcorp Precision Medicine Product Portfolio
  6.3.5 Labcorp Recent Developments
6.4 Abbott Laboratories
  6.4.1 Abbott Laboratories Comapny Information
  6.4.2 Abbott Laboratories Business Overview
  6.4.3 Abbott Laboratories Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.4.4 Abbott Laboratories Precision Medicine Product Portfolio
  6.4.5 Abbott Laboratories Recent Developments
6.5 Novartis
  6.5.1 Novartis Comapny Information
  6.5.2 Novartis Business Overview
  6.5.3 Novartis Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.5.4 Novartis Precision Medicine Product Portfolio
  6.5.5 Novartis Recent Developments
6.6 Illumina
  6.6.1 Illumina Comapny Information
  6.6.2 Illumina Business Overview
  6.6.3 Illumina Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.6.4 Illumina Precision Medicine Product Portfolio
  6.6.5 Illumina Recent Developments
6.7 GE Healthcare
  6.7.1 GE Healthcare Comapny Information
  6.7.2 GE Healthcare Business Overview
  6.7.3 GE Healthcare Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.7.4 GE Healthcare Precision Medicine Product Portfolio
  6.7.5 GE Healthcare Recent Developments
6.8 Intel Corporation
  6.8.1 Intel Corporation Comapny Information
  6.8.2 Intel Corporation Business Overview
  6.8.3 Intel Corporation Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.8.4 Intel Corporation Precision Medicine Product Portfolio
  6.8.5 Intel Corporation Recent Developments
6.9 Biomrieux Sa
  6.9.1 Biomrieux Sa Comapny Information
  6.9.2 Biomrieux Sa Business Overview
  6.9.3 Biomrieux Sa Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.9.4 Biomrieux Sa Precision Medicine Product Portfolio
  6.9.5 Biomrieux Sa Recent Developments
6.10 Cepheid
  6.10.1 Cepheid Comapny Information
  6.10.2 Cepheid Business Overview
  6.10.3 Cepheid Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.10.4 Cepheid Precision Medicine Product Portfolio
  6.10.5 Cepheid Recent Developments
6.11 IBM
  6.11.1 IBM Comapny Information
  6.11.2 IBM Business Overview
  6.11.3 IBM Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.11.4 IBM Precision Medicine Product Portfolio
  6.11.5 IBM Recent Developments
6.12 Qiagen
  6.12.1 Qiagen Comapny Information
  6.12.2 Qiagen Business Overview
  6.12.3 Qiagen Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.12.4 Qiagen Precision Medicine Product Portfolio
  6.12.5 Qiagen Recent Developments
6.13 Thermo Fisher Scientific
  6.13.1 Thermo Fisher Scientific Comapny Information
  6.13.2 Thermo Fisher Scientific Business Overview
  6.13.3 Thermo Fisher Scientific Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.13.4 Thermo Fisher Scientific Precision Medicine Product Portfolio
  6.13.5 Thermo Fisher Scientific Recent Developments
6.14 Randox Laboratories
  6.14.1 Randox Laboratories Comapny Information
  6.14.2 Randox Laboratories Business Overview
  6.14.3 Randox Laboratories Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.14.4 Randox Laboratories Precision Medicine Product Portfolio
  6.14.5 Randox Laboratories Recent Developments
6.15 Almac Group
  6.15.1 Almac Group Comapny Information
  6.15.2 Almac Group Business Overview
  6.15.3 Almac Group Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.15.4 Almac Group Precision Medicine Product Portfolio
  6.15.5 Almac Group Recent Developments
6.16 Healthcore
  6.16.1 Healthcore Comapny Information
  6.16.2 Healthcore Business Overview
  6.16.3 Healthcore Precision Medicine Revenue, Global Share and Gross Margin (2019-2024)
  6.16.4 Healthcore Precision Medicine Product Portfolio
  6.16.5 Healthcore Recent Developments

7 NORTH AMERICA

7.1 North America Precision Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Precision Medicine Market Size by Country (2019-2024)
7.3 North America Precision Medicine Market Size Forecast by Country (2025-2030)

8 EUROPE

8.1 Europe Precision Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Precision Medicine Market Size by Country (2019-2024)
8.3 Europe Precision Medicine Market Size Forecast by Country (2025-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific Precision Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Precision Medicine Market Size by Country (2019-2024)
9.3 Asia-Pacific Precision Medicine Market Size Forecast by Country (2025-2030)

10 LATIN AMERICA

10.1 Latin America Precision Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Precision Medicine Market Size by Country (2019-2024)
10.3 Latin America Precision Medicine Market Size Forecast by Country (2025-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Precision Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Precision Medicine Market Size by Country (2019-2024)
11.3 Middle East & Africa Precision Medicine Market Size Forecast by Country (2025-2030)

12 CONCLUDING INSIGHTS

13 APPENDIX

13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
  13.5.1 Secondary Sources
  13.5.2 Primary Sources


More Publications